Antigen-Specific Lymphocyte Retrieval via Droplet Microfluidics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for efficiently retrieving and sequencing antigen-specific lymphocytes, such as B cells and T cells, which are crucial for determining immune responses and developing targeted therapies like monoclonal antibodies.
Innovation Solution
A method involving sequential density fractionation, magnetic-activated cell sorting, and fluorescence-activated cell sorting to isolate and stimulate lymphocytes, followed by sequencing their receptors, allowing for the generation of receptor-dependent substances like monoclonal antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to retrieve and sequence antigen-specific lymphocytes, then the process is simple, but the efficiency and accuracy of identifying antigen-specific cells is insufficient
Solution Approach 1:
The method segments the lymphocyte retrieval process into distinct stages: first enriching for antigen-specific cells using antigen-specific antibodies, then isolating individual cells via droplet microfluidics, and finally sequencing their receptors. This segmentation allows each step to be optimized independently, improving overall efficiency while managing complexity through modularization.
Solution Approach 2:
The patent introduces droplet microfluidics as an intermediary technology that bridges cell enrichment and single-cell sequencing. The microfluidic droplets serve as intermediaries to individually encapsulate and transport enriched lymphocytes to sequencing platforms, enabling high-throughput processing without requiring complex direct integration between enrichment and sequencing systems.
2Measurement precision
If multiple sorting and enrichment steps are implemented to improve lymphocyte isolation accuracy, then the precision of antigen-specific cell identification increases, but the process time and operational complexity increase
Solution Approach 1:
The method performs preliminary enrichment of antigen-specific lymphocytes using antigen-specific antibodies before the main sorting and sequencing process. This preliminary action concentrates the target cells of interest, reducing the number of cells that need to be processed in subsequent steps and thereby decreasing overall processing time while maintaining high identification accuracy.
Solution Approach 2:
The patent replaces traditional mechanical cell sorting methods with droplet microfluidics-based single-cell isolation. This substitution enables parallel processing of thousands of cells simultaneously through automated droplet generation and sorting, dramatically reducing processing time compared to manual or sequential mechanical sorting methods while maintaining high precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the effective retrieval and sequencing of lymphocyte receptors, facilitating the development of targeted therapies and predicting immune responses to antigens or vaccines.
Implementation Method 1
magnetic-activated cell sorting
Implementation Method 2
fluorescence-activated cell sorting
Implementation Method 3
sequential density fractionation
Data Source
AI summary
This disclosure is directed to methods for retrieving and using at least one lymphocyte. Additionally, cell receptor sequences identified with this strategy could be used for antibody development, TCR discovery, or appropriate therapeutics development or evaluation.